Next Article in Journal
Medication Complexity among Disadvantaged African American Seniors in Los Angeles
Next Article in Special Issue
Qualitative Exploration of Pharmacists’ Feedback Following the Implementation of an “Allergic Rhinitis Clinical Management Pathway (AR-CMaP)” in Australian Community Pharmacies
Previous Article in Journal
A Narrative Review of Continuing Professional Development Needs for Pharmacists with Respect to Pre-exposure Prophylaxis (PrEP) for Human Immunodeficiency Virus (HIV)
Previous Article in Special Issue
Interventions Delivered in the Community Pharmacy to Manage Allergic Rhinitis- A Systematic Review of the Literature
Open AccessArticle

Managing Allergic Rhinitis in the Pharmacy: An ARIA Guide for Implementation in Practice

1
Faculty of Health Sciences and CICS—UBI, Health Sciences Research Centre, University of Beira Interior, 6200-506 Covilhã, Portugal
2
Woolcock Institute of Medical Research, Faculty of Medicine and Health, University of Sydney, Sydney 2037, Australia
3
UCIBIO, REQUIMTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing (AgeUPNetWork), University of Porto, 4150 Porto, Portugal
4
CINTESIS—Center for Health Technology and Services Research, Faculty of Medicine, University of Porto, 4200-450 Porto, Portugal
5
CIRFF, Center of Pharmacoeconomics, University of Naples Federico II, 80138 Naples, Italy
6
MACVIA-France, 34295 Montpellier, France
7
Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, 9000 Ghent, Belgium
8
Upper Airways Research Laboratory, ENT Dept, Ghent University Hospital, 9000 Ghent, Belgium
9
International Airway Research Center, First Affiliated Hospital Guangzhou, Sun Yat-sen University, Guangzhou 510275, China
10
Department of Medicine Solna, Immunology and Allergy Research Unit, Karolinska Institute, 171 77 Stockholm, Sweden
11
Department of Biochemistry and Clinical Chemistry, Faculty of Pharmacy with the Division of Laboratory Medicine, Warsaw Medical University, 02-091 Warsaw, Poland
12
Department of Clinical Pharmacy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania
13
Personalized Medicine Clinic Asthma & Allergy, Humanitas University, Humanitas Research Hospital, 20089 Rozzano MI, Italy
14
Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, 00100 Helsinki, Finland
15
Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Łódź, 90-419 Łódź, Poland
16
Department of Pharmacy, University of Naples Federico II, 80138 Naples, Italy
17
Department of Prevention of Environmental Hazards and Allergology, Warsaw Medical University, 02-091 Warsaw, Poland
18
Department of Health Research Methods, Evidence, and Impact, Division of Immunology and Allergy, McMaster University, Hamilton, ON L8S 4L8, Canada
19
College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL 33314, USA
20
Centre Hospitalier Universitaire de Montpellier, 34295 Montpellier, France
21
Charité—Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, 10117 Berlin, Germany
22
Comprehensive Allergy Center, Department of Dermatology and Allergy, Berlin Institute of Health, 10178 Berlin, Germany
*
Author to whom correspondence should be addressed.
Pharmacy 2020, 8(2), 85; https://doi.org/10.3390/pharmacy8020085
Received: 15 April 2020 / Revised: 12 May 2020 / Accepted: 15 May 2020 / Published: 16 May 2020
(This article belongs to the Special Issue Medicine Use in Upper Respiratory Airways and Asthma)
The paradigm of how we manage allergic rhinitis is shifting with a growing understanding that it is a complex process, requiring a coordinated effort from healthcare providers and patients. Pharmacists are key members of these integrated care pathways resolving medication-related problems, optimizing regimens, improving adherence and recommending therapies while establishing liaisons between patients and physicians. Community pharmacists are the most accessible healthcare professionals to the public and allergic rhinitis is one of the most common diseases managed by pharmacists. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines developed over the past 20 years have improved the care of allergic rhinitis patients through an evidence-based, integrated care approach. In this paper, we propose an integrated approach to allergic rhinitis management in community pharmacy following the 2019 ARIA in the pharmacy guidelines. View Full-Text
Keywords: allergic rhinitis; community pharmacy; pharmacist allergic rhinitis; community pharmacy; pharmacist
Show Figures

Figure 1

MDPI and ACS Style

Lourenço, O.; Bosnic-Anticevich, S.; Costa, E.; Fonseca, J.A.; Menditto, E.; Cvetkovski, B.; Kritikos, V.; Tan, R.; Bedbrook, A.; Scheire, S.; Bachert, C.; Białek, S.; Briedis, V.; Boussery, K.; Canonica, G.W.; Haahtela, T.; Kuna, P.; Novellino, E.; Samoliński, B.; Schünemann, H.J.; Wallace, D.; Bousquet, J. Managing Allergic Rhinitis in the Pharmacy: An ARIA Guide for Implementation in Practice. Pharmacy 2020, 8, 85.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop